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Dendritic cells have the potential to induce tolerance
and here we attempted to identify their role in the tolerance
seen in ischemic pre-conditioning. We induced bilateral
renal ischemic preconditioning in mice and then challenged
them with an ischemic insult 7 days later. Compared to
sham-operated controls, preconditioned mice were found
to have reduced injury with less inflammation, but had
an increased number of regulatory T cells (Tregs) in their
kidneys after the delayed insult. Splenocytes from these mice
had more Tregs and mature CD11cþ cells, but reduced
proliferative and cytokine-secretory responses, suggesting a
state of immunosuppression compared to control mice. Anti-
CD25 depletion followed by adoptive transfer of Tregs
partially mitigated and then restored the protective effect of
preconditioning. Depletion of CD11cþ cells with liposomes
containing clodronate was associated with partial loss of
preconditioning benefits. The increased numbers of Tregs
or impaired immune response found in splenocytes from
preconditioned mice were partially reversed in splenocytes
from liposome clodronate–treated animals, suggesting that
CD11cþ cells contribute to immune cell-mediated ischemic
preconditioning. Hence, our results show that ischemic
preconditioning of the kidney provides a negative signal
to the peripheral immune system, partially mediating
the tissue-protective and anti-inflammatory effects of
this maneuver.
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Ischemic preconditioning describes a phenomenon by virtue
of which transient ischemia/reperfusion (I/R) injury to an
organ confers a resistance to subsequent episodes of I/R
injury and several mechanisms, such as induction of heme
oxygenase-1, heat shock protein, or mitogen-activated
protein kinase activation in ischemic organs, have been
shown to be important.1,2 However, several recent reports
have demonstrated that the beneficial effect of ischemic
preconditioning is limited not only to local tissue but also to
remote organs, suggesting the presence of a systemic effect in
ischemic preconditioning.3,4 Since first reported in 1993 by
Przyklenk et al.,5 several recent randomized controlled trials
have demonstrated the promising results of remote ischemic
preconditioning (RIP) by utilizing limb ischemia to protect
the myocardium or contralateral limb from subsequent I/R
injury.6–8 There are several proposed mechanisms of RIP,
including neural and hormonal pathways, or the systemic
immune response pathway with anti-inflammatory effect.9
A recent report by Burne-Taney et al.10 suggested the possible
involvement of immune cells in mediating kidney ischemic
preconditioning by showing the protective effect of adop-
tively transferred splenocytes of mice on I/R day 5 into nu/nu
mice from subsequent I/R injury, and this immune cell
participation may be one other possible mechanism leading
to RIP. However, the precise phenotypic characteristics of
peripheral immune system in tolerogenic status that might
influence subsequent protection are not clear. Dendritic cells
(DCs) that belong to monocyte lineage are specialized
antigen-presenting cells with heterogenous phenotypes link-
ing innate and adaptive immunity and are known to be
important in induction of both immunity and tolerance. The
DC lineage, maturational status, or cytokine milieu at sites of
inflammation have all been implicated to be critical in
determining whether an immunogenic or tolerogenic T-cell
response will develop.11,12 Therefore, given the striking
functional plasticity of these cells, it is possible that DCs
might play an important role in mediating tolerance
induction in ischemic preconditioning. In the present study,
under the hypothesis that immune cell alteration or immune
suppressive signal following I/R might be important in
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mediating kidney ischemic preconditioning effect, we examined
the splenocytes’ immunophenotypes, including the percentage
of regulatory T cells (Tregs), phenotype of CD11cþ cells, and
the proliferative and cytokine-secretory properties upon various
stimuli. We also examined the role of Tregs in ischemic
preconditioning by using anti-CD25 depletion and adoptive
transfer strategies. In addition, we examined the role of
CD11cþ cells by using liposome clodronate in an immune
cell-mediated tolerance induction mechanism in kidney
ischemic preconditioning. We observed that tolerogenic I/R
day 7 splenocytes were characterized by an increased percentage
of Tregs and more mature CD11cþ cells with tolerogenic
phenotype. Kidney Tregs also increased in preconditioned
ischemic kidneys, and depletion and adoptive transfer of Tregs
was associated with partial loss and recovery of beneficial effect
of ischemic preconditioning. Splenocytes from tolerogenic
animals also showed a significantly decreased proliferative
response upon T-cell receptor (TCR) stimulation and an
impaired cytokine-secretory property upon lipopolysaccharide
(LPS) stimulation. However, the phenotypic characteristics of
these splenocytes were partially reversed by systemic CD11cþ
cell depletion, and these changes were also associated with
partial loss of beneficial effect of kidney ischemic precondi-
tioning. Our results suggest that Tregs and/or CD11cþ
macrophages/DCs might partially mediate immune cell-
mediated tolerance induction in ischemic preconditioning.
Further studies identifying the precise mechanisms of tolerance
induction may hasten the development of various strategies in
the prevention or treatment of acute kidney injury (AKI).
RESULTS
Delayed ischemic preconditioning attenuated the functional,
histological kidney injury
As expected, delayed kidney ischemic preconditioning signif-
icantly attenuated the functional, histological kidney injury
(Figures 1a and b). Compared with previous sham-operated
ischemic kidneys with extensive tubular injury, characterized
by tubular cell necrosis, dilation of tubules, and cast formation in
the outer medulla, kidneys from preconditioned ischemic animals
showed less tubular injury. The number of TdT-mediated dNTP
nick end labeling-positive tubular cells was also markedly
decreased by ischemic preconditioning (Figure 1c). Tissue
inflammation, assessed by Ly6G immunohistochemical staining,
also showed the anti-inflammatory effect of ischemic precondi-
tioning. Ly6G-positive neutrophil infiltration observed along the
course of outer stripes of the outer medulla in previous sham-
operated ischemic kidneys markedly decreased in pre-
conditioned ischemic kidneys (Figure 2a). Among several cyto-
kines and chemokines, only interleukin (IL)-6 level showed a
correlation with tissue inflammation, with significantly decreased
tissue IL-6 levels in preconditioned ischemic kidneys (Figure 2b).
Tolerogenic status is associated with an increased percentage
of spleen CD4þ Foxp3þ Tregs and percentage of kidney
Tregs increased in preconditioned ischemic kidneys
In order to examine the mechanisms of immune cell-
mediated tolerance mechanisms, we obtained splenocytes
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Figure 1 | Effect of delayed ischemic preconditioning on
kidney function and histology. Following sham or ischemia/
reperfusion (I/R) injury on day 0, a second I/R injury was done
on day 7 and animals were killed for various analyses on day 8.
(a) Serum creatinine (Cr) after second I/R. Serum Cr significantly
decreased in preconditioned I/Rþ I/R mice. (b) Kidney histology,
periodic acid-Schiff,  40. (c) TdT-mediated dNTP nick end
labeling (TUNEL)-positive cells, TUNEL staining,  100. Tubular
cell injury and apoptosis significantly decreased in I/Rþ I/R mice.
*Po0.05 compared with sham, **Po0.05 compared with shamþ I/R
(n¼ 5–7 per group).
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from sham day 7 or tolerogenic I/R day 7 and examined
the splenocyte immunophenotypes. We first determined the
percentage of CD4þ Foxp3þ Tregs in the spleen that had
been known to be important in tolerance induction in
various autoimmune and transplantation animal models.
The percentage of splenocyte CD4þ Foxp3þ Tregs was
slightly but significantly increased in tolerogenic I/R day 7
mice compared with sham-operated animals (7.36±0.52% vs
5.29±0.12% from CD4þ cells, Po0.05; Figure 3a). In
addition, we checked the percentage of kidney Tregs 24 h after
second I/R. Compared with shamþ I/R, the percentage of
CD4þ Foxp3þ Tregs increased significantly in kidneys from
I/Rþ I/R (Figure 3b).
Tregs partially contribute to the protective effect of ischemic
preconditioning
To determine the functional significance of increased Treg
population in ischemic preconditioning, we used depletion
and adoptive transfer strategy. Administration of anti-
CD25mAb significantly decreased the number of splenic
Tregs and the Treg depletion was accompanied by partial loss
of preconditioning effect. In addition, we observed that the
adoptive transfer of these cells back into Treg-depleted mice
partially restored the protective effect of ischemic precondi-
tioning (Figures 3c and d), suggesting the important
contribution of Tregs in ischemic preconditioning. Trans-
ferred Tregs were identified in the spleen, lymph nodes, and
also in kidneys (Figure 3e), but not in the liver and lungs
(data not shown). The intensity of GFP-positive cells can be
appreciated by 40,6-diamidino-2-phenylindole counterstaining.
Decreased proliferation and impaired cytokine secretion of
splenocytes in tolerogenic I/R day 7 animals
For further analyses of splenocyte function, we measured the
proliferative response of splenocytes upon TCR stimulation
and also the cytokine-secretory properties upon LPS
stimulation. Compared with splenocytes from sham-oper-
ated animals that showed proliferation upon combined anti-
CD3 and anti-CD28 antibody (Ab) stimulation, splenocytes
from I/R day 7 mice showed a significantly decreased
proliferative response determined by bromodeoxyuridine
(BrdU) incorporation (Figure 4a). In addition, the splenocyte
cytokine-secretory properties upon LPS stimulation were also
measured. LPS simulation markedly increased the produc-
tion of tumor necrosis factor-a, interferon-g, and monocyte
chemotactic protein-1 in the splenocytes of sham-operated
animals. However, splenocytes from I/R day 7 mice showed
significant impairment in secretion of proinflammatory
cytokines and chemokines upon LPS stimulation (Figure 4b).
CD11cþ cells from I/R day 7 animals show different
phenotype
A higher percentage of CD11cþ cells in the I/R day 7 mice
expressed co-stimulatory molecules compared with those
from sham-operated animals (Figure 5a). Among cytokines,
IL-10 and IL-6 levels were significantly higher in CD11cþ
cells from I/R day 7 mice compared with those from sham-
operated mice (Figure 5b), suggesting that CD11Cþ cells in
I/R day 7 mice were in a more mature stage compared with
those in sham-operated mice. However, no detectable IL-12
p70 was found in DCs from tolerogenic animals, possibly
suggesting that they reside in semi-mature DCs that are
known to induce tolerance by promoting differentiation of
Tregs from naı¨ve CD4þ T cells (Figure 5a).
Liposome clodronate injection resulted in systemic depletion
of CD11cþ CD11bþ cells and was associated with partial loss
of the beneficial effect of ischemic preconditioning
Liposome clodronate injection following initial I/R resulted
in significant depletion of CD11bþ CD11cþ cells in
peripheral blood and spleens. Depletion of CD8þ CD11cþ
cells that are known to be lymphoid DCs was also observed
(Figure 6).
Systemic depletion of CD11cþ cells before second I/R was
associated with partial loss of the beneficial effect of kidney
ischemic preconditioning on kidney function and histology.
The decreased serum creatinine level and tubular damage
observed in preconditioned ischemic kidneys showed a
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Figure 2 | Effect of delayed ischemic preconditioning on
kidney inflammation. Following sham or ischemia/reperfusion
(I/R) injury on day 0, a second I/R injury was done on
day 7 and animals were killed for various analyses on day 8.
(a) Immunohistochemistry for Ly6G,  100. (b) Tissue cytokines
by cytometric bead array. Ly6Gþ neutrophil infiltration into
kidney tissue and kidney interleukin (IL)-6 level markedly increased
in shamþ I/R mice and significantly decreased in I/Rþ I/R.
*Po0.05 compared with sham, **Po0.05 compared with
shamþ I/R (n¼ 5–7 per group). IFN-g, interferon-g; TNF-a, tumor
necrosis factor-a.
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partial reversal by liposome clodronate injection following
initial I/R (Figures 7a and b). The anti-inflammatory effect of
ischemic preconditioning also partially disappeared by
liposome clodronate injection (Figure 7c), and the markedly
decreased tissue IL-6 level in preconditioned ischemic kidney
also showed a partial reversal, suggesting that the beneficial
effect of kidney ischemic preconditioning might be partially
mediated by CD11cþ macrophages/DCs. As IL-10 has been
known to be associated with DC–Treg interaction, we
measured the kidney IL-10 level and also performed
immunohistochemical localization. IL-10-positive cells were
mainly localized to the inner medulla and papilla. Compared
with sham-operated kidneys, the number and staining
intensity of IL-10-positive cells in papilla seem to increase
in I/R day 7 kidneys. However, the difference between I/R day
7 and I/Rþ liposome clodronate day 7 is not remarkable
(Figure 7d). IL-10 protein level from total kidney extracts
also showed no significant difference between the two groups
(Figure 7e).
Splenocyte phenotypes in tolerogenic animals were partially
reversed by liposome clodronate injection
In the analysis of splenocyte phenotypes, the increased
percentage of CD4þ Foxp3þ Tregs, or decreased prolifera-
tive response upon TCR stimulation and impaired cytokine-
secretory properties upon LPS stimulation, which were all
observed in splenocytes from tolerogenic animals, were
partially reversed in liposome clodronate-injected precondi-
tioned animals, suggesting the important role of DC/
macrophages in mediating peripheral immune suppressive
signal following I/R (Figure 8).
DISCUSSION
In the present study, we demonstrated the following: (i)
delayed kidney ischemic preconditioning provided marked
functional and histological kidney protection with less tissue
inflammation; (ii) splenocytes from the tolerogenic I/R day 7
state were characterized by an increased percentage of Tregs,
significantly decreased proliferative response upon TCR
stimulation, and also impaired cytokine-secretory property
upon LPS stimulation; (iii) depletion and adoptive transfer of
Tregs partially mitigated and restored the protective effect of
ischemic preconditioning; (iv) CD11cþ macrophages/DCs
from the tolerogenic I/R day 7 state are thought to be in a
more mature stage with high surface expression of co-
stimulatory molecules, higher IL-6 and IL-10 secretion; (v)
systemic DC/macrophage depletion by liposome clodronate
injection following I/R was associated with partial loss of the
beneficial effect of ischemic preconditioning; and (vi)
increased Tregs or less proliferative and cytokine-secretory
response, all observed in splenocytes from tolerogenic I/R
day 7 state, showed a partial reversal by liposome clodronate
injection. These results demonstrated that ischemic precon-
ditioning induced peripheral immune tolerance status that is
characterized by expansion of Tregs and more mature CD11cþ
cells and thus might suggest that Tregs or macrophage/
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Figure 4 | Splenocytes of tolerogenic ischemia/reperfusion
(I/R) day 7 animals showed decreased proliferative response
upon mitogenic stimuli, and impaired secretion of cytokines
and chemokine-secretory response upon lipopolysaccharide
(LPS) stimulation. Following sham or I/R injury on day 0, animals
were killed on day 7 and mononuclear cells from spleen were
obtained for various analyses. (a) Spleen mononuclear cells from
sham day 7 or I/R day 7 were cultured with or without anti-mouse
CD3 antibody (Ab)/anti-mouse CD28 Ab for 72 h and, following
incubation with bromodeoxyuridine (BrdU) for 18 h, the amount
of BrdU incorporation was measured. Compared with sham-
operated mice, spleen MNCs from I/R day 7 mice showed
significantly decreased proliferative response. (b) Spleen MNCs
from sham day 7 or I/R day 7 mice were cultured in the presence
of LPS for 24 h and cytokine and chemokine production was
measured in the supernatants. Compared with sham-operated
mice, spleen MNCs from I/R day 7 mice showed significantly
impaired cytokine secretion. *Po0.05 compared with sham
day 7 (n¼ 5–6 per group). IFN-g, interferon-g; IL, interleukin;
MCP-1, monocyte chemotactic protein-1; TNF-a, tumor necrosis
factor-a.
Figure 3 |CD4þ Foxp3 regulatory T cells (Tregs) contribute to the beneficial effect of ischemic preconditioning. (a) Following sham
or ischemia/reperfusion (I/R) injury on day 0, mice were killed on day 7 and mononuclear cells from spleen were obtained for various
analyses. Flow-cytometric detection of CD4þ Foxp3þ Tregs and percentage of Tregs out of the total number of CD4þ cells. The
percentage of spleen Tregs increased in tolerogenic I/R day 7 mice. (b) Following sham or I/R injury on day 0, a second I/R injury was done
on day 7 and animals were killed on day 8. Flow-cytometric detection of kidney CD4þ Foxp3þ Tregs in sham, shamþ I/R, and I/Rþ I/R mice
was done. The percentage of kidney Tregs increased in preconditioned ischemic kidneys (I/Rþ I/R) compared with shamþ I/R. (c) Serum
creatinine (Cr) after second I/R in Treg-depleted or adoptively transferred mice. Treg depletion by using CD25mAb (PC61) or adoptive
transfer of CD4þ Foxp3þ GFPþ cells partially mitigated or restored the protective effect of ischemic preconditioning. *Po0.05 compared
with sham day 7, **Po0.05 compared with shamþ I/R, #Po0.05 compared with I/Rþ I/R, ##Po0.05 compared with I/Rþ PC61þ I/R, n¼ 4–5
per group. (d) Kidney histology showed loss of protective effect of ischemic preconditioning in Treg-depleted mice and also partial reversal
of injury in mice with adoptive transfer of Tregs, periodic acid-Schiff,  100. (e) Detection of adoptively transferred Tregs in various tissues.
Mice were treated with CD4þ GFPþ Tregs from Foxp3EGFP mice (A–C) or phosphate-buffered saline (D–F) on day 2 following Treg depletion
after initial I/R as described in Methods, and tissues were processed for immunofluorescence microscopy 1 day after the second I/R. All
pictures were counterstained with 40,6-diamidino-2-phenylindole. Original magnification,  400. (A, D) Lymph node; (B, E) spleen; (C, F)
kidney. IgG, immunoglobulin G.
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DC-mediated immune suppression is thought to contribute
to tolerance induction in ischemic preconditioning.
Ischemic preconditioning represents an endogenous
adaptive response that provides local protection against
subsequent I/R injury and the beneficial effect of ischemic
preconditioning is thought to result from local activation of
mitogen-activated protein kinase, induction of heat shock
protein, or inducible nitric oxide synthase.1,2,13 However,
recent observations that the beneficial effect of ischemic
preconditioning is limited not only to local tissues but also to
remote organs suggests that the preconditioning effect might
also be systemically mediated.3,4 Among the several proposed
mechanisms of RIP, a systemic anti-inflammatory response
following I/R that is associated with immune cell alteration
might be an attractive, novel mechanism. Burne-Taney et al.
previously reported the possible involvement of immune
cells in kidney ischemic preconditioning by showing the
protective effect of adoptively transferred splenocytes isolated
from I/R day 5 animals to nu/nu mice from subsequent I/R
injury compared to those from sham day 5 animals.10 In our
study, we focused on the peripheral immune response in
preconditioned mice to examine the possible contribution of
systemic immune response in ischemic preconditioning. We
observed that the tolerogenic I/R day 7 state was associated
with peripheral immune-suppressive signals that were
characterized by an increased percentage of Tregs and
CD11cþ macrophages/DCs with more mature phenotype.
A depressed peripheral immune system following I/R injury
to other organs has also been reported. Offner et al.14 showed
that early activation of systemic immunity was followed later
by profound immunosuppression characterized by increased
CD4þ FoxP3þ Tregs in an ischemic stroke mouse model.
They claimed that this profound peripheral immunosuppres-
sion might result in increased infectious complications,
which is a frequent medical complication diagnosed in
stroke patients. In another study, Konstantinov et al.15 also
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Figure 5 |CD11cþ spleen macrophages/dendritic cells (DCs) in tolerogenic state are in their semi-mature stage. Spleen CD11Cþ DCs
were separated by using magnetic-assisted cell sorting (MACS) and flow-cytometric detection of their maturation status and cytokine
production was examined. (a) Percentages of CD80- or CD86-expressing CD11cþ spleen DCs were measured. The percentage of CD11cþ
cells that express the activation marker was significantly increased in ischemia/reperfusion (I/R) day 7 mice. (b) Spleen CD11cþ DCs were
cultured overnight in 96-well plates and their cytokine production was measured. Secretion of interleukin (IL)-6 and IL-10 was significantly
increased in CD11cþ cells from I/R day 7 animals compared with those from sham day 7 animals. *Po0.05 compared with sham day 7
(n¼ 4). IFN-g, interferon-g; MHC II, major histocompatibility complex II; TNF-a, tumor necrosis factor-a.
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Figure 6 | Effect of liposome clodronate administration after initial ischemia/reperfusion (I/R) injury on blood and spleen CD11bþ
CD11cþ macrophages/dendritic cells (DCs). Liposome clodronate was injected on days 1 and 3 following initial I/R injury, and on
day 7 mice were killed. Flow-cytometric detection of CD11bþ CD11cþ DCs or CD8þ CD11cþ DCs was performed. (a) After gating
monocytes, flow-cytometric detection of CD11bþ CD11cþ DCs in blood was performed. Depletion of CD11bþ CD11cþ cells compared
with CD11bþ CD11c cells was evident. (b) Flow-cytometric analyses of spleen CD11bþ CD11cþ and CD8þ CD11cþ cells. More
preferential depletion of CD11bþ CD11cþ compared with CD8þ CD11cþ is evident. *Po0.05 compared with sham day 7, **Po0.05
compared with I/R day 7 (n¼ 4–5). APC, allophycocyanin; LC, liposome clodronate.
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demonstrated suppression of inflammatory gene transcrip-
tion in circulating leukocytes following brief forearm
ischemia using microarray methods. The suppressed genes
in that study were those involved in cytokine synthesis,
leukocyte chemotaxis, adhesion or migration, and innate
immunity signaling pathways. Transcriptosome change was
evident within 15min (early-phase IPC) or 24 h (delayed-
phase IPC) following ischemia.15 This change in immune
cells toward impaired activation is likely to contribute to less
inflammation and organ injury upon subsequent I/R because
tissue inflammation has been known to be very important in
pathogenesis of I/R-induced AKI.
CD4þ CD25þ Tregs are important in suppression of
immune responses and also in induction of tolerance in
various injury models, and recently several reports have
demonstrated a beneficial effect of CD4þ CD25þ cells in
Th-1-mediated diseases by using Treg depletion strate-
gies.16–20 We observed that the relative percentage of Tregs
in spleen increased in tolerogenic I/R day 7 mice. Although
the magnitude of increase in splenic Tregs in I/R day 7 mice
or increase in kidney Tregs in I/Rþ I/R mice was small, the
role of Tregs in ischemic preconditioning was proved to be
important because partial depletion and adoptive transfer of
Tregs partially mitigated and restored the beneficial effect of
ischemic preconditioning. Recently, the protective role of
Tregs in kidney I/R injury has been reported. By using three
different animal models to modulate Tregs, Kinsey et al.21
demonstrated that Tregs have a protective role in I/R injury
through IL-10-mediated suppression of innate immunity.
Gandolfo et al.22 also reported that Tregs have an important
role in recovery phase following I/R. They also observed
significantly increased trafficking of Tregs into the kidney at 3
and 10 days after I/R, respectively. Therefore, Tregs are likely
to contribute not only to the repair process in I/R injury but
also to the tolerance induction mechanism upon subsequent
injury.
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Besides the increase in Treg population, splenocytes from
tolerogenic I/R day 7 animals also showed significantly
different functions following various stimuli. The prolifera-
tive response against combined anti-CD3 and anti-CD28
antibody stimulation was significantly impaired, suggesting
the possible anti-proliferative effect of the pre-expanded
Treg population. In addition, splenocytes from tolerogenic
animals also showed an impaired cytokine response upon
LPS stimulation. Despite the well-established suppressive
function of Tregs in the pathogenic T-cell response, the
mechanism leading to impairment of T-cell-independent
cytokine-secretory response upon LPS stimulation in this
study is not certain. However, according to several reports,
Tregs could also suppress acute-phase or innate immune
responses via several different mechanisms.23–25 Kinsey
et al.21 also showed that I/R injury in Treg-depleted state
resulted in increased kidney neutrophil and macrophage
infiltration, suggesting the role of Tregs in suppressing innate
immune response in vivo. This impaired innate immune
response of splenocytes to LPS stimulation in tolerogenic
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animals could also be one other possible mechanism that
contributes to protection from subsequent I/R injury wherein
inflammatory responses have an important role. We also
observed a marked decrease in Ly6Gþ neutrophil infiltration
in preconditioned ischemic kidneys. Among tissue cytokines,
IL-6, a well-known inflammatory cytokine, also decreased signif-
icantly in preconditioned ischemic kidneys. In contrast, the
levels of other cytokines, such as tumor necrosis factor-a and
interferon-g, did not show any difference between the groups.
Macrophages and DCs are all derived from monocyte/
macrophage-lineage common precursor cells in bone marrow
and share many surface markers, including CD11c and F4/80,
and can only be discriminated by their functions, which are
often very difficult to demonstrate in an in-vivo system.
DCs are professional antigen-presenting cells linking innate
and adaptive immunity and exert important functions in
induction of both immunity and tolerance.11,12,26 Among
several mechanisms involved in peripheral tolerance induc-
tion by DCs, induction of Tregs by tolerogenic DCs has
recently been documented.27,28 Therefore, we hypothesized
that CD11cþ DCs might have a crucial role in mediating
tolerance induction, because we observed that ischemic
preconditioning was associated with immunological toler-
ance that was characterized by increased spleen Tregs, and
also by impaired immune response of splenocytes against
mitogenic and non-mitogenic stimuli. However, because of
the absence of a specific surface marker that can identify DCs,
we used the CD11cþ population and designated them as
CD11cþ macrophages/DCs. We first found that the percen-
tage of peripheral blood CD11cþ CD11bþ cells that are
likely to be myeloid DCs increased significantly in the
tolerogenic I/R day 7 state. The Offner study also observed an
increased percentage of CD11bþ macrophages/monocytes in
peripheral blood 4 days following ischemic stroke. On the
assumption that macrophage population is not present in
peripheral blood, the authors raised the possibility that these
CD11bþ cells might represent tolerogenic DCs that poten-
tiated the activation of Tregs and simultaneously reduced the
activation of effector T cells, as in our study.14 Although an
increase in these cells was not detected in the splenocytes, we
performed a phenotypic analysis of spleen CD11cþ macro-
phages/DCs. A higher percentage of splenic CD11cþ cells
expressed activation markers in I/R day 7 animals and they
secreted more IL-10 and IL-6. According to classical theory,
splenic CD11cþ cells from I/R day 7 mice are thought to be
in their semi-mature stage because they secrete more IL-6
and IL-10, but not detectable IL12p70, with a relatively
higher surface expression of co-stimulatory molecules. It is
currently believed that tolerogenic DCs can only be defined
by their function, rather than by their specific lineage.
Promotion of conversion from naı¨ve CD4þ T cells to Tregs
and release of IL-10 are thought to be mechanisms under-
lying tolerogenic DCs and DCs in the semi-mature stage of
maturation, as in our study, are known to induce tolerance by
promoting differentiation from naı¨ve T cells into Tregs in
vitro and in vivo.27,29–31 To examine the possible role of IL-10
in the protective effect of ischemic preconditioning, we
measured IL-10 levels and also performed immunolocaliza-
tion in sham day 7 or tolerogenic I/R day 7 kidney tissues.
Unexpectedly, IL-10-positive cells were mainly identified in
renal papilla and compared with sham kidneys, and the
number of IL-10-positive cells and staining intensity
increased in I/R day 7 kidneys. This parallels with the kidney
IL-10 level measured by cytometric bead array, showing a
significant induction of IL-10 in preconditioned kidneys.
However, we could not detect any significant reduction of
IL-10- or IL-10-positive cell number in liposome clodronate-
treated preconditioned kidneys. Therefore, the role of IL-10
in DC–Treg interaction in ischemic preconditioning needs to
be further assessed.
In this study, systemic CD11cþ macrophage/DC deple-
tion induced by liposome clodronate injection resulted in
partial loss of the beneficial effect of kidney ischemic
preconditioning on kidney function and histology. The
anti-inflammatory effect observed in preconditioned is-
chemic kidneys was also partially lost in these cell-depleted
preconditioned kidneys. This is in contrast with a previous
report demonstrating that infiltrated macrophage did not
affect ischemic preconditioning.32 However, the authors of
that study used a quite different depletion strategy in that
liposome clodronate was administered on day 6 after initial
I/R. Given that the possible DC–Treg interaction in precondi-
tioning might need several days, and also according to a
recent paper by Kim et al.,33 who demonstrated that
phenotypic change in kidney DCs already occurred on day
3 following I/R, depletion strategy in our study seems to be
more reasonable. However, more importantly, we observed
that the immunophenotype alterations of splenocytes
observed in tolerogenic I/R day 7 animals were also partially
reversed by systemic CD11cþ cell depletion, further indicat-
ing that these CD11cþ macrophages/DCs might participate
in immune cell-mediated tolerance induction in kidney
ischemic preconditioning. The percentage of CD4þ CD25þ
Tregs that increased in tolerogenic I/R day 7 animals
decreased significantly in CD11cþ cell-depleted animals. In
addition, less proliferative response upon TCR stimulation or
impaired cytokine-secretory property upon LPS challenge,
presumably due to expanded Treg population in tolerogenic
splenocytes, also showed a partial reversal by systemic
CD11cþ cell depletion. Despite several meaningful findings,
controversies regarding the specificity of cell types still exist.
However, because of the overlapping surface marker, using
CD11c-DTR transgenic mice might also bring about the
same result of nonspecific depletion of macrophages/DCs.
The recent view is that macrophages are immature DCs, DCs
are immature macrophages, and that conversion between
these two cell types can be achieved according to environ-
mental milieu. Liposome clodronate injection in our study
did not affect other cell types, with a significant effect on
systemic CD11cþ CD11bþ cells, and this depletion was
associated with partial loss of ischemic preconditioning
effect.
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In summary, we have provided evidence that kidney I/R
injury induced a strong negative signal to the peripheral
immune system that is thought to be partially mediated by
Tregs and/or CD11cþ macrophages/DCs. Profound immu-
nosuppression following initial I/R might contribute to a
beneficial effect of kidney ischemic preconditioning. Re-
cently, trials utilizing genetically modified tolerogenic DCs
for tolerance induction are getting more attention for
possible clinical application in various autoimmune diseases
or organ transplantation. Identifying the mechanisms
involved in peripheral tolerance induction might be an
attractive way for developing various strategies in the
prevention or treatment of AKI.
METHODS
Animals
Six-to-eight week-old male C57BL/6 (weight, 20–25 g) or Foxp3EGFP
mice (Jackson Laboratory, Bar Harbor, ME, USA) were used. They
were provided standard food and water and all animal procedures
were in accordance with the criteria established by the Animal Care
Committee of Korea University for the care and use of laboratory
animals in research.
Experimental design
We performed a well-established delayed kidney ischemic precondi-
tioning animal model. Mice were subjected to bilateral renal pedicle
clamping for 30min or a sham operation on day 0 and were
subjected to an additional 30min of bilateral ischemia on day 7.
Animals were killed on day 8 and biochemical and histological
examinations were done. For another set of experiments to
determine the functional significance of Tregs in ischemic
preconditioning, we used depletion and adoptive transfer strategies.
Anti-CD25mAb or control IgG was administered intraperitoneally
on the same day of initial I/R and a second I/R injury was done on
day 7. For adoptive transfer of Tregs, CD4þ GFPþ cells from
Foxp3EGFP mice were isolated and administered to Treg-depleted
mice on day 3 following the initial I/R injury (shamþ I/R vs I/Rþ
I/R vs I/RþPC61þ I/R vs I/RþPC61þTregsþ I/R).
The serum creatinine level was measured using a Hitachi 747
automatic analyzer (Black Scientific Inc., Bohemia, NY, USA) and
histological kidney injury was examined in periodic acid Schiff-
stained kidney tissue sections. Apoptotic cells in paraffin-embedded
kidney tissue sections were identified using ApopTagPlus (Intergen,
Purchase, NY, USA) and the number of apoptotic cells in the outer
medulla was semi-quantitatively measured by counting 8–10 HPF
( 200) sections and compared between the groups. For assessment
of tissue inflammation, the number of Ly6G-positive neutrophil-
infiltrated cells in the outer medulla were counted and the tissue
cytokine and chemokine levels were measured by cytometric bead
array (Mouse Inflammation Kit, BD Bioscience, San Jose, CA, USA).
Immunohistochemistry for IL-10 was also performed in vehicle/
liposome clodronate-treated kidneys (I/R day 7 vs I/Rþ LC day 7)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
In vivo trafficking of adoptively transferred Tregs
In a separate set of mice, CD4þ GFPþ Tregs from Foxp3EGFP mice
(1 105) were adoptively transferred following depletion of Tregs (I/
RþTreg depletionþTregs) on day 3 following initial I/R. On day 7
a second I/R was done and on day 8 mice were perfusion fixed with
phosphate-buffered saline (PBS) and 4% paraformaldehyde, and
kidneys, lung, spleen, lymph nodes, and liver were proceeded with
sequential fixation with 5% sucrose in PBS overnight at 41C, 30%
sucrose in PBS for 8 h at 41C, and frozen at 701C. Fluorescence
microscopy was applied on 4–8-m cryosections. Cryosections of
thickness 3 mm were cut, air-dried, rinsed, and then mounted using
Vectashield mouting media with 40,6-diamidino-2-phenylindole
(Vector Laboratories, Burlingame, CA, USA). Indirect immuno-
fluorescence microscopic images were obtained with Olympus
BX51, and collected using ImagePro software (Mediacybernetics,
Bethesda, MD, USA).
Liposome clodronate for depletion of CD11cþ
macrophages/DCs
In a separate experiment, to examine the role of CD11cþ
macrophages/DCs in kidney ischemic preconditioning, liposome
clodronate or PBS was injected on days 1 and 3 following initial I/R.
Flow cytometric detection of blood and spleen CD11bþ CD11cþ or
CD8þ CD11cþ cells on day 7 following I/R was done to confirm
the systemic depletion of CD11cþ cells. Mice were then subjected to
additional I/R injury on day 7 and killed on day 8, and all the
parameters that were previously mentioned were measured again to
define the role of CD11cþ cells in kidney ischemic preconditioning
(shamþ I/R vs I/Rþ I/R vs I/Rþ liposome clodronateþ I/R).
Isolation of spleen mononuclear cells (MNCs), flow cytometry,
and measurement of proliferative and cytokine-secretory
responses
In order to examine the mechanisms of immune cell-mediated
tolerance induction in kidney ischemic preconditioning, MNCs
from spleens of sham day 7 (sham day 7), tolerogenic I/R day 7 (I/R
day 7), or liposome clodronate-treated I/R day 7 (I/Rþ liposome
clodronate day 7) mice were isolated and their phenotypic
characteristics were compared. For flow-cytometric analysis of
Tregs, Abs to mouse CD4 and Foxp3 (eBioscience, San Diego, CA,
USA) were used. For measurement of proliferative response, 5 105
splenocytes were cultured in the presence of mouse anti-CD3 and
anti-CD28 Abs (BD BioCoatTM Mouse T-cell Activation Plates, BD
Bioscience) for 48 h; the cells were labeled with BrdU for 18 h, the
amount of BrdU incorporated was determined, and fold difference
compared with that of negative control . To determine the innate
immune response of splenocytes, 5 105 splenocytes were cultured
for 24 h in the presence or absence of LPS (1 mg/ml, Escherichia coli
O26:B6; Sigma Aldrich, St Louis, MO, USA) and the cytokine
secretion in the supernatants was measured by cytometric bead array
using a mouse inflammation kit.
Isolation, phenotyping of spleen CD11cþ macrophages/DCs
In order to examine the phenotypic differences of CD11cþ cells
between sham-operated (sham day 7) and tolerogenic animals (I/R
day 7), we isolated spleen CD11cþ cells by using magnetic-assisted
cell sorting. The degree of co-stimulatory molecule expression
(CD80, CD86, and major histocompatibility complex II) and also
cytokine secretion was measured.
Determination of kidney CD4þ Foxp3þ Tregs
Kidney single-cell suspension from sham, shamþ I/R, or I/Rþ I/R
mice was obtained and mononuclear cells were isolated by using
Ficoll gradient. Following staining with anti-mouse CD45-PE Ab
and anti-mouse CD4-FITC Ab, cells were fixed and permeabilized
for intracellular Foxp3 staining and flow-cytometric detection of
kidney Tregs was performed.
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Statistical analysis
All data were expressed as mean±s.e. and analyzed using Sigmastat.
A Student t-test or non-parametric Mann–Whitney U-test was used
to determine the statistical significance between the groups and a
P-value o0.05 was considered to be statistically significant.
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